Skip to main content
. 2023 Mar 14;45(3):347–365. doi: 10.1007/s00281-023-00987-3

Fig. 3.

Fig. 3

Overview on the signaling pathways and affinity of the four known subtypes of adenosine receptors (ARs), stimulatory (+) and inhibitory (–) compounds used in the cited studies on OGD or in vivo ischemic stroke and their role in brain ischemia. For details, see Supplementary Table 2. Images from BioRender.com